Virica Biotech products

Viral Medicines are the Way of the Future. Gene therapies and vaccines save and protect human life. The COVID-19 pandemic highlights the criticality of vaccine development today and into the future. The pandemic also highlights the challenges drug developers and manufacturers face. To achieve meaningful yields of viral medicines, you rely on living cells, grown at scale, in specialized equipment. You need to achieve these yields in tight timeframes. You require effectiveness.  Manufacturing complex and effective viral medicines at scale needs to be achieved. How do you increase yield? How do you increase effectiveness?